EUVIMEDEUVIMED entdecken
Crossref

Synthesis, characterization of ultrasmall gold nanocluster conjugated with Gemcitabine for anticancer activity

Tushar Tyagi, Raghu Solanki, Sunita Patel, Prasenjit Maity

Medical Oncology · 2025

DOI: 10.1007/s12032-025-02810-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2025. Verfasst von Tushar Tyagi und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering and Technology, National Forensic Sciences University, Gandhinagar, 382007, India. Hauptthemen laut MEDLINE: Deoxycytidine, Gold, Metal Nanoparticles, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of effective drug delivery strategy by employing novel nano-careers are advantageous for targeted and controlled drug release. The present work describes about such a strategy in the form of a protein stabilized ultrasmall gold nanocluster as nano-career for the delivery of anticancer drug Gemcitabine (Gem). Gold nanocluster (AuNCs) stabilized by bovine serum albumin (BSA) was synthesized and characterized in detail including its stability, size distribution, toxicity, and photo-physical properties. It was revealed that monodispersed gold particles (~ 1.5 nm) dispersible in aqueous phase with unique optical absorption and emission characteristics (λabs = 450 nm, λemi = 650 nm), high stability and minimum toxicity was obtained. Afterward, an anticancer drug (Gem) was conjugated with the gold cluster through simple chemical mixing resulting in the formation of 55% drug load Au nanocluster (Gem-AuNCs-BSA). The resultant Gem-AuNCs-BSA showed enhanced delivery of drug and therapeutic effects for the treatment of breast cancer and lung cancer with better efficacy than free Gemcitabine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeoxycytidineGoldMetal NanoparticlesAntimetabolites, AntineoplasticAntineoplastic AgentsGemcitabineHumansSerum Albumin, BovineFemaleCell Line, TumorAnimalsDrug Delivery SystemsBreast NeoplasmsLung Neoplasms

Stichwörter der Autor:innen

AnticancerBSAGemcitabineGold nanoclusterMTT Assay

Substanzen

GemcitabineDeoxycytidineGoldSerum Albumin, BovineAntimetabolites, AntineoplasticAntineoplastic Agents

Autor:innen und Institutionen

  • School of Engineering and Technology, National Forensic Sciences University, Gandhinagar, 382007, India.
  • School of Life Sciences, Central University of Gujarat, Gandhinagar, 382030, India.
  • School of Life Sciences, Central University of Gujarat, Gandhinagar, 382030, India. sunitap@cug.ac.in.
  • School of Engineering and Technology, National Forensic Sciences University, Gandhinagar, 382007, India. prasenjit.maity@nfsu.ac.in.
  • School of Forensic Science, National Forensic Sciences University, Guwahati, 781032, India. prasenjit.maity@nfsu.ac.in.

Zitieren

APA

Tyagi, T., Solanki, R., Patel, S., & Maity, P. (2025). Synthesis, characterization of ultrasmall gold nanocluster conjugated with Gemcitabine for anticancer activity. Medical Oncology. https://doi.org/10.1007/s12032-025-02810-5

Vancouver

Tyagi T, Solanki R, Patel S, Maity P. Synthesis, characterization of ultrasmall gold nanocluster conjugated with Gemcitabine for anticancer activity. Medical Oncology. 2025. doi:10.1007/s12032-025-02810-5

BibTeX
@article{Tyagi2025,
  author = {Tyagi, Tushar and Solanki, Raghu and Patel, Sunita and Maity, Prasenjit},
  title = {Synthesis, characterization of ultrasmall gold nanocluster conjugated with Gemcitabine for anticancer activity},
  journal = {Medical Oncology},
  year = {2025},
  doi = {10.1007/s12032-025-02810-5}
}
Kostenlos starten →